The Latest Cardiac and Vascular News
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY–(BUSINESS WIRE)–Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of […]
– PULSAR Phase 2 trial results published in New England Journal of Medicine – – Updates from the PULSAR and SPECTRA Phase 2 trials of sotatercept in patients with pulmonary arterial hypertension (PAH) to be presented at the American Thoracic Society (ATS) 2021 International Conference on May 19, 2021 – […]
The Board of Directors warmly thanks Dr. Philippe Pouletty, Managing Director of Truffle Capital, for his exceptional contribution to the development of the CARMAT project, and proposes the appointment of three new directors, Florent Battistella, David Coti and John B. Hernandez. CARMAT (FR0010907956, ALCAR), the designer and developer of the […]
Revenue of $28.7 million, up 133% year over year Operating loss of $(2.9) million, a 52% improvement year over year Adjusted EBITDA of $1.9 million, achieving consecutive quarterly positive Adjusted EBITDA Record quarterly cash flow from operations of $6.4 million, compared to $(3.1) million in Q1 2020 Jonathan Mayhew joins […]
– A new, first-of-its-kind study known as TAP-CHF leverages expertise across Abbott’s cardiovascular portfolio to optimize treatment for patients suffering from both AFib and heart failure – The trial will utilize Abbott technology including cardiac ablation and sensors to monitor for both pulmonary artery pressure and abnormal heartbeats – Historically, […]
Company Earns “Best Hospital Technology Implementation” Recognition for System-Wide Expansion of Rhythm CI Remote Telemetry ST. LOUIS, May 6, 2021 /PRNewswire/ — Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced that the company has been recognized by MedTech Breakthrough for the second consecutive year. The company earned recognition for the “Best Hospital […]
– Second fiscal quarter revenues of $4.9 billion grew 15.4% on a reported basis. On a currency-neutral basis, revenues increased 12.2%. – BD’s COVID-19 testing sales were $480 million, including BD Veritor™ Plus System revenues of $290 million. – BD’s core growth led by strong growth in Medication Delivery Solutions […]
WESTMINSTER, Colo., May 05, 2021 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Christopher Graybill, Ph.D., has joined ARCA as Vice President, Clinical Development. Dr. Michael Bristow, ARCA’s President and Chief Executive Officer, […]
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies OAKLAND, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced that it has been selected as the winner of the “Best Use of Artificial Intelligence in Healthcare” award in the fifth annual MedTech […]
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume Analysis guided management of acute decompensated heart failure (ADHF) utilizing […]
